EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Amicus Therapeutics, Inc. (FOLD) EBITDA Margin data is not available.
| Income Statement Financials | |
$169.06M |
|
$17.31M |
|
$19.47M |
|
$149.59M |
|
$134.79M |
|
$34.27M |
|
$0.01M |
|
$34.27M |
|
$34.27M |
|
$17.31M |
|
$17.31M |
|
$17.31M |
|
$17.31M |
|
$34.27M |
|
$36.80M |
|
308.47M |
|
310.43M |
|
$0.06 |
|
$0.06 |
|
| Balance Sheet Financials | |
$594.07M |
|
$27.76M |
|
$274.75M |
|
$868.81M |
|
$198.93M |
|
$391.99M |
|
$439.46M |
|
$638.39M |
|
$230.42M |
|
$17.88M |
|
$230.42M |
|
308.49M |
|
| Cash Flow Statement Financials | |
$16.89M |
|
$-39.94M |
|
$-13.42M |
|
$216.72M |
|
$193.86M |
|
$-22.86M |
|
$60.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.99 |
|
-- |
|
-- |
|
0.63 |
|
1.70 |
|
88.49% |
|
20.27% |
|
20.27% |
|
|
EBITDA Margin |
-- |
20.27% |
|
10.24% |
|
$13.89M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.11 |
|
1.49 |
|
60.60 |
|
7.51% |
|
96.77% |
|
1.99% |
|
2.78% |
|
$0.75 |
|
$0.04 |
|
$0.05 |
|